Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8333633 | 0.87 | CYP3A4 (0.44) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL27675106 | 0.84 | TDP1 (0.45) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL28217274 | 0.84 | MEN1 (0.45) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL28137972 | 0.83 | CYP3A4 (0.41) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL11231441 | 0.83 | MYC (0.42) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL7863941 | 0.83 | MEN1 (0.44) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL10630705 | 0.82 | NOTUM (0.42) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL10625931 | 0.82 | CYP3A4 (0.48) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL4314431 | 0.79 | KDM4E (0.50) | CYP3A4TSHRALDH1A1TP53CASP1 | |
| SCHEMBL2149302 | 0.79 | AKR1C2 (0.52) | TSHRALDH1A1TP53CASP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9238657-B2 | Cephalosporin having catechol group | SHIONOGI & CO., LTD. (JP) | 2016-01-19 | — | — | US | disclosed |
| US-20110190254-A1 | CEPHALOSPORIN HAVING CATECHOL GROUP | SHIONOGI & CO., LTD. (JP) | 2011-08-04 | — | — | US | disclosed |
| WO-2001083420-A2 | METHOD OF MAKING SUBSTITUTED DIHALO AROMATIC ACID CHLORIDES | OCCIDENTAL CHEMICAL CORPORATION (US) | 2001-11-08 | — | — | WO | disclosed |
| US-6303812-B1 | ADDING WATER TO A MIXTURE CONTAINING A CUPROUS HALIDE, CUPROUS ACETATE OR PROPIONATE, AND CERTAIN DEHALOGENATED AROMATIC PRODUCTS, SUCH AS METHYL 3,5-DICHLORO-4-METHYLBENZOATE, CAUSES THE MIXTURE TO SEPARATE INTO ORGANIC AND AQUEOUS PHASES | OCCIDENTAL CHEMICAL CORPORATION | 2001-10-16 | — | — | US | disclosed |
| US-6118018-A | Chlorination and bromination of aromatic compounds at atmospheric pressure | OCCIDENTAL CHEMICAL CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190254-A1 | CEPHALOSPORIN HAVING CATECHOL GROUP | NRDC, LUC7L2, NR0B1 | CYP3A4 1037/4885TSHR 2183/4885ALDH1A1 2808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.